STOCK TITAN

ALLO (ALLO) Form 144 shows planned sale of 22,900 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ALLO had a Form 144 filed to permit the sale of 22,900 shares of its common stock through Morgan Stanley Smith Barney LLC on or about 02/02/2026, to be sold on NASDAQ with an aggregate market value of $40,214.69.

The shares were acquired on 01/31/2026 as restricted stock vesting under a registered compensation plan, with compensation listed as the form of payment. The filing notes that 224,730,144 shares of common stock were outstanding.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for ALLO disclose?

The filing discloses a planned sale of 22,900 ALLO common shares on NASDAQ through Morgan Stanley Smith Barney LLC, with an aggregate market value of $40,214.69. It is a notice of intent to sell restricted stock that recently vested under a registered compensation plan.

How many ALLO shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 22,900 shares of ALLO common stock. These shares are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, reflecting an aggregate market value of $40,214.69 at the time indicated in the filing.

When were the ALLO shares being sold under Form 144 acquired?

The 22,900 ALLO shares were acquired on January 31, 2026, as restricted stock vesting under a registered plan. The filing identifies the issuer as the source of the shares and lists compensation as the nature of payment for this vesting transaction.

What is the approximate sale date and market for the ALLO Form 144 shares?

The filing lists an approximate sale date of February 2, 2026, for the 22,900 ALLO shares. The shares are to be sold on the NASDAQ exchange, using Morgan Stanley Smith Barney LLC as the broker for executing the transactions.

How many ALLO shares were outstanding according to this Form 144?

The document states that 224,730,144 shares of ALLO common stock were outstanding. This figure provides context for the relative size of the planned 22,900-share sale described in the Form 144 notice filed for the account of the selling holder.
Allogene Therapeutics

NASDAQ:ALLO

ALLO Rankings

ALLO Latest News

ALLO Latest SEC Filings

ALLO Stock Data

391.03M
158.71M
17.45%
74.09%
8.99%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO